Home › Sjogren's Syndrome › Maryland
Sjogren's Syndrome clinical trials in Maryland
6 studies for Sjogren's Syndrome are looking for participants at sites in Maryland.
Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 2, 2026 · NCT07281456The Pathogenesis and Natural History of Sjogren's Disease
- National Institutes of Health Clinical Center, Bethesda
RecruitingObservational study
Ages 16 to 100 · All sexes · Updated Oct 2, 2026 · NCT01425892Characterization of Diseases With Salivary Gland Involvement
- National Institutes of Health Clinical Center, Bethesda
RecruitingObservational studyHealthy volunteers welcome
Ages 4 to 100 · All sexes · Updated Oct 1, 2026 · NCT02327884Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
- Arthritis and Rheumatism Associates, Rockville
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 27, 2026 · NCT07404865The Myelin Disorders Biorepository Project
- Kennedy Krieger Institute, Baltimore
RecruitingObservational study
All ages · All sexes · Updated Oct 23, 2025 · NCT03047369From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.